Globus Medical
GMED
431 hedge funds and large institutions have $5.43B invested in Globus Medical in 2023 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 210 increasing their positions, 73 reducing their positions, and 41 closing their positions.
188% more repeat investments, than reductions
Existing positions increased: 210 | Existing positions reduced: 73
131% more call options, than puts
Call options by funds: $18.1M | Put options by funds: $7.81M
124% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 41
13% more funds holding
Funds holding: 382 → 431 (+49)
12% more capital invested
Capital invested by funds: $4.84B → $5.43B (+$593M)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
11.26% less ownership
Funds ownership: 104.5% → 93.23% (-11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$209M |
| 2 |
BlackRock
New York
|
+$206M |
| 3 |
State Street
Boston,
Massachusetts
|
+$69.4M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$66.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$65.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$57.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$55.8M |
| 3 |
TAL
TIG Advisors LLC
New York
|
-$43.6M |
| 4 |
Select Equity Group
New York
|
-$32.6M |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
-$28.5M |
GMED Hedge Fund Activity: Q3 2023 in Review
431 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2023, worth a combined $5.43B — up 12% from $4.84B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new GMED positions and 41 closed out — a net gain of 51 holders — while 210 added to existing stakes and 73 trimmed.
The largest buyer was Vanguard Group, adding an estimated $209M. The largest seller was Millennium Management, cutting an estimated $57.8M.
- 431 institutional investors held Globus Medical (GMED) as of Q3 2023, up from 382 in Q2 2023.
- Funds reported $5.43B of Globus Medical stock for Q3 2023, up 12% quarter-over-quarter.
- 92 funds opened new Globus Medical positions in Q3 2023 and 41 closed out, a net change of +51 holders.
- The largest Globus Medical buyer in Q3 2023 was Vanguard Group, an estimated $209M added.
- The largest Globus Medical seller in Q3 2023 was Millennium Management, an estimated $57.8M sold.
Based on aggregated 13F filings for Q3 2023.